肾上腺危象
医学
肾上腺功能不全
促肾上腺皮质激素
原发性肾上腺功能不全
呕吐
氢化可的松
腹痛
肾上腺皮质功能不全
糖皮质激素
生活质量(医疗保健)
儿科
内科学
重症监护医学
激素
护理部
作者
Eystein S. Husebye,Simon H. S. Pearce,Nils Krone,Olle Kämpe
出处
期刊:The Lancet
[Elsevier]
日期:2021-01-20
卷期号:397 (10274): 613-629
被引量:197
标识
DOI:10.1016/s0140-6736(21)00136-7
摘要
Adrenal insufficiency can arise from a primary adrenal disorder, secondary to adrenocorticotropic hormone deficiency, or by suppression of adrenocorticotropic hormone by exogenous glucocorticoid or opioid medications. Hallmark clinical features are unintentional weight loss, anorexia, postural hypotension, profound fatigue, muscle and abdominal pain, and hyponatraemia. Additionally, patients with primary adrenal insufficiency usually develop skin hyperpigmentation and crave salt. Diagnosis of adrenal insufficiency is usually delayed because the initial presentation is often non-specific; physician awareness must be improved to avoid adrenal crisis. Despite state-of-the-art steroid replacement therapy, reduced quality of life and work capacity, and increased mortality is reported in patients with primary or secondary adrenal insufficiency. Active and repeated patient education on managing adrenal insufficiency, including advice on how to increase medication during intercurrent illness, medical or dental procedures, and profound stress, is required to prevent adrenal crisis, which occurs in about 50% of patients with adrenal insufficiency after diagnosis. It is good practice for physicians to provide patients with a steroid card, parenteral hydrocortisone, and training for parenteral hydrocortisone administration, in case of vomiting or severe illness. New modes of glucocorticoid delivery could improve the quality of life in some patients with adrenal insufficiency, and further advances in oral and parenteral therapy will probably emerge in the next few years.
科研通智能强力驱动
Strongly Powered by AbleSci AI